Mineralys Therapeutics Inc (MLYS)

06:10 AM

Mineralys Therapeutics, Inc. $MLYS Shares Sold by Quadrature Capital Ltd - MarketBeat

06:10 AM

03:54 AM

Is Mineralys Therapeutics Inc. stock a buy for dividend growthJuly 2025 Market Mood & Long-Term Safe Investment Ideas - Newser

03:54 AM

03:06 AM

How Mineralys Therapeutics Inc. stock valuations compare to rivalsQuarterly Market Summary & Daily Oversold Stock Bounce Ideas - Newser

03:06 AM

Dec 03, 2025

This Fund Leaned Into 2025's Big Biotech Rally with a $9.5 Million Bet on Mineralys - AOL.com

Dec 03, 2025

Dec 03, 2025

AZ uses a priority review voucher for baxdrostat filing - pharmaphorum

Dec 03, 2025

Dec 02, 2025

Mineralys Awards New Hire Stock Option as Hypertension Pipeline Advances - MSN

Dec 02, 2025

Dec 02, 2025

AstraZeneca Moves Ahead of Mineralys With Fast Baxdrostat Review - Citeline News & Insights

Dec 02, 2025

Dec 02, 2025

Virtus Investment Advisers LLC Sells 7,192 Shares of Mineralys Therapeutics, Inc. $MLYS - MarketBeat

Dec 02, 2025

Dec 02, 2025

Prudential Financial Inc. Increases Stake in Mineralys Therapeutics, Inc. $MLYS - MarketBeat

Dec 02, 2025

Dec 02, 2025

Will Mineralys Therapeutics Inc. stock rally after Fed decisions - Newser

Dec 02, 2025

Dec 01, 2025

How Investors May Respond To Mineralys Therapeutics (MLYS) After $287.5 Million Upsized Capital Raise and New Institutional Backing - Sahm

Dec 01, 2025

Nov 30, 2025

Ensign Peak Advisors Inc Raises Holdings in Mineralys Therapeutics, Inc. $MLYS - MarketBeat

Nov 30, 2025

Nov 29, 2025

(MLYS) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com

Nov 29, 2025

Nov 29, 2025

A Look at Mineralys Therapeutics (MLYS) Valuation After Findell Capital’s Major New Investment - Yahoo Finance

Nov 29, 2025

Nov 29, 2025

Mineralys Therapeutics, Inc. $MLYS Shares Bought by Franklin Resources Inc. - MarketBeat

Nov 29, 2025

Nov 26, 2025

Is Mineralys Therapeutics Inc a good long term investmentDividend Stock Watch & Free Stock Chart Pattern Guides - earlytimes.in

Nov 26, 2025

Nov 26, 2025

Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Nov 26, 2025

Nov 26, 2025

Mineralys Therapeutics reports inducement award under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com

Nov 26, 2025

Nov 26, 2025

Mineralys Therapeutics (Nasdaq: MLYS) grants 146K-share inducement option over 4 years - Stock Titan

Nov 26, 2025

Nov 24, 2025

Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling - Investing.com

Nov 24, 2025

Nov 24, 2025

Mineralys Therapeutics Insider Sold Shares Worth $43,350,000, According to a Recent SEC Filing - MarketScreener

Nov 24, 2025

Nov 23, 2025

Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN

Nov 23, 2025

Nov 22, 2025

Catalys Pacific fund sells Mineralys Therapeutics shares for $43.35m By Investing.com - Investing.com Australia

Nov 22, 2025

Nov 21, 2025

Mineralys Therapeutics, Inc.Common Stock (Nasdaq:MLYS) Stock Quote | PRN_FinancialWrapper | PR Newswire - Markets Financial Content

Nov 21, 2025

Nov 21, 2025

Director’s Major Stock Sale Shakes Up Mineralys Therapeutics! - TipRanks

Nov 21, 2025

Nov 21, 2025

Catalys Pacific fund sells Mineralys Therapeutics shares for $43.35m - Investing.com

Nov 21, 2025

Nov 21, 2025

[Form 4] Mineralys Therapeutics, Inc. Insider Trading Activity - Stock Titan

Nov 21, 2025

Nov 19, 2025

Momentum divergence signals in Mineralys Therapeutics Inc. chartJuly 2025 Institutional & Weekly Stock Performance Updates - newser.com

Nov 19, 2025

Nov 19, 2025

What moving averages say about Mineralys Therapeutics Inc.Trade Exit Report & Community Consensus Picks - newser.com

Nov 19, 2025

Nov 19, 2025

How rising interest rates impact Mineralys Therapeutics Inc. stock2025 Risk Factors & Safe Capital Allocation Plans - newser.com

Nov 19, 2025

Nov 19, 2025

Will Mineralys Therapeutics Inc. stock benefit from commodity pricesNew Guidance & Free Safe Entry Trade Signal Reports - newser.com

Nov 19, 2025

Nov 19, 2025

Mineralys Nears Pivotal FDA Filing as Hypertension Drug Lorundrostat Advances - MSN

Nov 19, 2025

Nov 19, 2025

Is Mineralys Therapeutics Inc. stock positioned for digital transformationTrade Performance Summary & Safe Swing Trade Setups - newser.com

Nov 19, 2025

Nov 19, 2025

A Fresh Look at Mineralys Therapeutics (MLYS) Valuation After Narrower Q3 Loss and $300M Shelf Registration - Sahm

Nov 19, 2025

Nov 19, 2025

How Mineralys Therapeutics Inc. stock performs in rate cut cyclesJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - newser.com

Nov 19, 2025

Nov 18, 2025

Can Mineralys Therapeutics Inc. hit a new high this monthEarnings Performance Report & Free AI Powered Buy and Sell Recommendations - newser.com

Nov 18, 2025

Nov 18, 2025

Ranking Mineralys Therapeutics Inc. among high performing stocks via toolsEarnings Miss & Weekly Watchlist of Top Performers - newser.com

Nov 18, 2025

Nov 18, 2025

(MLYS) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com

Nov 18, 2025

Nov 17, 2025

MLYS Stock Price Dives 11% After Mixed Securities Filing - StocksToTrade

Nov 17, 2025

Nov 16, 2025

Will Mineralys Therapeutics Inc. stock recover faster than marketJobs Report & High Accuracy Swing Entry Alerts - newser.com

Nov 16, 2025

Nov 16, 2025

How Mineralys Therapeutics Inc. stock reacts to Fed rate cutsJuly 2025 Selloffs & High Yield Equity Trading Tips - newser.com

Nov 16, 2025

Nov 16, 2025

Will Mineralys Therapeutics Inc. stock remain a Wall Street favoriteBear Alert & Real-Time Stock Movement Alerts - newser.com

Nov 16, 2025

Nov 16, 2025

Price action breakdown for Mineralys Therapeutics Inc.Trade Exit Summary & Real-Time Buy Zone Alerts - newser.com

Nov 16, 2025